Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) Institutional Ownership

CUSIP: 39868T105

13F Institutional Holders and Ownership History from Q3 2018 to Q1 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
GRTS on Nasdaq
Shares outstanding
160,529,963
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 39868T105?
CUSIP 39868T105 identifies GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Redmile Group, LLC 8.2% $131,635 13,163,457 Redmile Group, LLC 31 Dec 2024

Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$773 0
2024 Q4 68,866 $773 -$20,647,950 $0.01 2
2024 Q3 35,628,372 $20,661,928 -$4,308,184 $0.58 55
2024 Q2 39,212,556 $24,236,603 -$19,716,392 $0.62 75
2024 Q1 46,863,208 $120,418,820 +$12,687,383 $2.57 84
2023 Q4 42,085,723 $85,856,544 -$11,439,635 $2.04 88
2023 Q3 48,612,900 $83,617,044 -$4,320,891 $1.72 88
2023 Q2 50,962,397 $99,490,547 +$7,005,623 $1.95 86
2023 Q1 46,273,450 $128,634,074 +$4,987,326 $2.78 89
2022 Q4 44,081,544 $152,081,792 +$37,336,995 $3.45 89
2022 Q3 33,453,341 $85,974,736 -$4,329,965 $2.57 76
2022 Q2 35,170,357 $85,107,364 -$17,400,543 $2.42 81
2022 Q1 39,953,370 $164,926,021 -$163,393,442 $4.12 112
2021 Q4 49,079,808 $629,881,488 +$66,066,934 $12.86 112
2021 Q3 42,395,927 $458,360,639 +$86,031,471 $10.80 90
2021 Q2 34,818,530 $317,890,500 +$6,996,481 $9.13 99
2021 Q1 34,045,816 $321,066,530 +$42,420,523 $9.43 96
2020 Q4 31,980,460 $126,010,396 +$37,330,969 $3.94 67
2020 Q3 22,817,492 $60,471,300 -$31,865,053 $2.65 64
2020 Q2 29,186,352 $193,788,948 -$4,335,520 $6.64 79
2020 Q1 29,847,520 $173,782,820 +$3,188,518 $5.82 64
2019 Q4 26,131,590 $234,363,395 +$5,808,914 $8.97 55
2019 Q3 28,600,546 $246,958,867 -$1,661,860 $8.64 61
2019 Q2 28,735,810 $319,969,665 +$114,720,746 $11.14 62
2019 Q1 18,365,380 $244,257,932 +$2,566,754 $13.30 52
2018 Q4 18,138,333 $278,950,649 +$62,505,876 $15.45 51
2018 Q3 11,087,129 $156,944,000 +$156,936,999 $14.24 43